Revilab ML-08
Longevity & Cellular HealthAlso known as: Revilab ML 08, ML-08
Bioregulators (Revilab Series)Research phase: Clinical use in Russia, no Western trialsRegulatory: Not FDA-approved. Available as bioregulator supplement in Russia and from international suppliers.
Mechanism
Revilab ML-08 is a multi-component capsule formulation targeting the urinary system. It combines kidney, bladder, and thymic bioregulatory peptides with renal-supportive nutrients.
Technical detail
Revilab ML-08 is a multi-component oral capsule containing bioregulatory peptides corresponding to Pielotax (kidney), Chitomur (bladder), and Vladonix (thymic) cytomax sequences, combined with cranberry extract, D-mannose, and vitamin C. It targets simultaneous nephroprotection, urothelial barrier support, and immune modulation for comprehensive urinary system health.